RegentAtlantic Capital’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$2.18M Buy
35,350
+1,429
+4% +$88.2K 0.07% 200
2022
Q2
$2.1M Buy
33,921
+538
+2% +$33.3K 0.07% 206
2022
Q1
$1.99M Sell
33,383
-1,619
-5% -$96.3K 0.06% 224
2021
Q4
$2.54M Buy
35,002
+876
+3% +$63.6K 0.07% 190
2021
Q3
$2.38M Buy
34,126
+1,211
+4% +$84.6K 0.07% 183
2021
Q2
$2.27M Buy
32,915
+930
+3% +$64.1K 0.07% 190
2021
Q1
$2.07M Buy
31,985
+2,079
+7% +$134K 0.07% 186
2020
Q4
$1.74M Sell
29,906
-21,479
-42% -$1.25M 0.07% 187
2020
Q3
$3.25M Sell
51,385
-35,939
-41% -$2.27M 0.15% 123
2020
Q2
$6.72M Buy
87,324
+45,410
+108% +$3.49M 0.37% 62
2020
Q1
$3.13M Buy
41,914
+2,580
+7% +$193K 0.24% 97
2019
Q4
$2.56M Sell
39,334
-9,168
-19% -$596K 0.16% 146
2019
Q3
$3.07M Buy
48,502
+1,893
+4% +$120K 0.2% 124
2019
Q2
$3.15M Buy
46,609
+4,013
+9% +$271K 0.21% 118
2019
Q1
$2.77M Buy
42,596
+8,886
+26% +$578K 0.19% 121
2018
Q4
$2.11M Sell
33,710
-10,205
-23% -$638K 0.18% 137
2018
Q3
$3.39M Sell
43,915
-9,621
-18% -$743K 0.26% 102
2018
Q2
$3.79M Sell
53,536
-6,282
-11% -$445K 0.33% 85
2018
Q1
$4.51M Buy
59,818
+1,746
+3% +$132K 0.38% 76
2017
Q4
$4.16M Buy
58,072
+3,147
+6% +$225K 0.34% 79
2017
Q3
$4.45M Buy
54,925
+1,713
+3% +$139K 0.39% 72
2017
Q2
$3.77M Buy
53,212
+1,198
+2% +$84.8K 0.34% 79
2017
Q1
$3.53M Buy
52,014
+9,280
+22% +$630K 0.33% 81
2016
Q4
$3.06M Sell
42,734
-15,531
-27% -$1.11M 0.3% 89
2016
Q3
$4.61M Buy
58,265
+1,796
+3% +$142K 0.48% 58
2016
Q2
$4.71M Buy
56,469
+8,773
+18% +$732K 0.45% 56
2016
Q1
$4.38M Sell
47,696
-4,290
-8% -$394K 0.48% 50
2015
Q4
$5.26M Buy
51,986
+25,870
+99% +$2.62M 0.56% 55
2015
Q3
$2.56M Buy
26,116
+20,124
+336% +$1.98M 0.25% 102
2015
Q2
$702K Buy
5,992
+169
+3% +$19.8K 0.06% 222
2015
Q1
$571K Buy
5,823
+50
+0.9% +$4.9K 0.05% 233
2014
Q4
$544K Sell
5,773
-790
-12% -$74.5K 0.05% 240
2014
Q3
$699K Buy
6,563
+936
+17% +$99.7K 0.07% 214
2014
Q2
$467K Buy
5,627
+2,546
+83% +$211K 0.04% 258
2014
Q1
$218K Buy
3,081
+214
+7% +$15.1K 0.02% 326
2013
Q4
$215K Buy
+2,867
New +$215K 0.02% 331